Bo Brink
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
-
- Organ Donation and Transplantation
- Palliative Care and End-of-Life Issues
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Cancer-related gene regulation 1
-
- Organ Donation and Transplantation 2
- Co-authors
- Carl‐Gustaf Elinder (2 shared papers)Ingela Fehrman‐Ekholm (2 shared papers)Jerry F. Schlegel (1 shared paper)Code Cf (1 shared paper)Peter Svalander (1 shared paper)J Wróblewski (1 shared paper)Ingrid Blikstad (1 shared paper)Per Odin (1 shared paper)
- Journals
- Transplantation (2 papers)Journal of Nephrology (1 paper)PROTOPLASMA (1 paper)Gut (1 paper)PubMed (1 paper)
- Partner nations
- SwedenUnited States
In The Last Decade
Bo Brink
7 papers receiving 377 citations
Peers
Comparison fields: 5 of 53
- Transplantation 40
- Public Health, Environmental and Occupational Health 261
- Gastroenterology 37
- Pulmonary and Respiratory Medicine 109
- Nephrology 23
Countries citing papers authored by Bo Brink
This map shows the geographic impact of Bo Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Brink more than expected).
Fields of papers citing papers by Bo Brink
This network shows the impact of papers produced by Bo Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Brink. The network helps show where Bo Brink may publish in the future.
Co-authors
The 14 scholars most cited alongside Bo Brink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 218 | |
| 2 | 2000 | 120 | |
| 3 | 1965 | 54 | |
| 4 | 1988 | 7 | |
| 5 | 1994 | 5 | |
| 6 | 2016 | 2 | |
| 7 | [An unusual case of a side effect. Cefotaxime-induced confusion in a patient with renal failure]. | 2003 | 1 |
About Bo Brink
Bo Brink is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Cell Biology, Pharmacology and Physiology, having authored 7 papers that have together received 407 indexed citations. Recurring topics across this work include Organ Donation and Transplantation (2 papers), Cell Adhesion Molecules Research (1 paper), Proteoglycans and glycosaminoglycans research (1 paper), Glycosylation and Glycoproteins Research (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Drug-Induced Adverse Reactions (1 paper), Cancer-related gene regulation (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Transplantation (40 citations), Public Health, Environmental and Occupational Health (261 citations), Gastroenterology (37 citations), Pulmonary and Respiratory Medicine (109 citations) and Nephrology (23 citations). Bo Brink has collaborated with scholars based in Sweden and United States. Frequent co-authors include Carl‐Gustaf Elinder, Ingela Fehrman‐Ekholm, Jerry F. Schlegel, Code Cf, Peter Svalander, J Wróblewski, Ingrid Blikstad, Per Odin, Magnus Hansson and Mia von Euler. Their work appears in journals such as Transplantation, Journal of Nephrology, PROTOPLASMA, Gut and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.